Farmaseuttisen kemian laitos
Department of Pharmaceutical Chemistry

Julkaisut 2005
Publications 2005

Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.


1 Azhayev AV et al. Advancements in oligonucleotide synthesis.
2 Callaway J et al. Efficacy of dietary hempseed oil in patients with atopic dermatitis.
3 Callaway J et al. Seasonal variations in [3H]citalopram platelet binding between healthy controls and violent offenders in Finland.
4 Callaway JC. Fast and slow metabolizers of hoasca.
5 Callaway JC. Various alkaloid profiles in decoctions of Banisteriopsis caapi.
6 Callaway JC et al. Phytochemical analyses of Banisteriopsis caapi and Psychotria viridis.
7 Cuypers A et al. Analysis of bean (Phaseolus vulgaris L.) proteins affected by copper stress.
8 Edwards JE et al. Role of P-glycoprotein in distribution of nelfinavir across the blood-mammary tissue barrier and blood-brain barrier.
9 Forsberg MM et al. The role of physicochemical properties of entacapone and tolcapone on their efficacy during local intrastriatal administration.
10 Hakkarainen J et al. Human and bovine milk oligosaccharides inhibit Neisseria meningitidis pili attachment in vitro.
11 Hartikainen S et al. The use of psychotropics and survival in demented elderly individuals .
12 Holappa J et al. N-chloroacyl-6-O-triphenylmethylchitosans: Useful intermediates for synthetic modifications of chitosan.
13 Jarho EM et al. Dicarboxylic acid azacycle L-prolyl-pyrrolidine amides as prolyl oligopeptidase inhibitors and three-dimensional quantitative structure-activity relationship of the enzyme-inhibitor interactions.
14 Juntunen J. Water-Soluble Prodrugs of Cannabinoids.
15 Juntunen J et al. In-vitro corneal permeation of cannabinoids and their water-soluble phosphate ester prodrugs.
16 Jyrkkärinne J et al. Amino acids important for ligand specificity of the human constitutive androstane receptor.
17 Järvinen T et al., keksijä. Lignaanikomplekseja.
18 Kokkola T et al. The functional role of cysteines adjacent to the NRY motif of the human MT1 melatonin receptor.
19 Korhonen LE et al. Predictive three-dimensional quantitative structure-activity relationship of cytochrome P450 1A2 inhibitors .
20 Korhonen O et al. Partial least square projections to latent structures analysis (PLS) in evaluating and predicting drug release from starch acetate matrix tablets.
21 Korjamo T et al. Absorption properties and P-glycoprotein activity of modified Caco-2 cell lines.
22 Korolainen MA et al. Proteomic analysis of glial fibrillary acidic protein in Alzheimer´s disease and aging brain.
23 Kulak TI et al. Synthesis of pyrimidine 1´,3´-anhydro-beta-D-psico- and -sorbo-furanosyl nucleosides.
24 Kumpulainen H et al. An efficient strategy for the synthesis of 1-chloroethyl phosphates and phosphoramidates.
25 Laitinen M-L et al. Variation in birch (Betula pendula) shoot secondary chemistry due to genotype, environment, and ontogeny.
26 Lapinjoki SP. Quality and stability of biopharmaceuticals.
27 Lehesranta SJ et al. Comparison of tuber proteomes of potato varieties, landraces, and genetically modified lines.
28 Loftsson T et al. Cyclodextrins in drug delivery.
29 Mannila A et al. Inefficient central nervous system delivery limits the use of ibuprofen in neurodegenerative diseases.
30 Mannila J et al. Effects of RM-beta-CD on sublingual bioavailability of Delta9-tetrahydrocannabinol in rabbits.
31 Mikhailopulo IA et al. Comparative conformational analysis of nucleosides by NMR, X-ray, and semi-empirical (PM3 VS. AM1) methods.
32 Niemi R et al. Synthesis, hydrolysis, and intraocular pressure lowering effects of fadolmidine prodrugs.
33 Palmgrén JJ et al. Quantitative determination of cholesterol, sitosterol, and sitostanol in cultured Caco-2 cells by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry.
34 Rahnasto M et al. Quantitative structure - activity relationship analysis of inhibitors of the nicotine metabolizing CYP2A6 enzyme.
35 Raitio KH et al. Targeting the cannabinoid CB2 receptor: Mutations, modeling and development of CB2 selective ligands.
36 Saario SM et al. Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes.
37 Salo OMH et al. Virtual screening of novel CB2 ligands using a comparative model of the human cannabinoid CB2 receptor .
38 Savinainen JR et al. Identification of WIN55212-3 as a competitive neutral antagonist of the human cannabinoid CB2 receptor.
39 Savolainen J, Järvinen T. Yliopisto-osaamisen siirtäminen elinkeinoelämään.
40 Savolainen J, Mannila A. Veri-aivoeste lääkekehityksen haasteena.
41 Savolainen J et al. Fadolmidine-induced ocular hypotension in normotensive rabbits.
42 Sivets GG et al. Synthesis of 9-[2-O-(2-methoxyethyl)-beta-D-ribofuranosyl]purines using 1-methanesulfonyloxy-2-methoxyethane.
43 Suihko E et al. Prediction of contact angle for pharmaceutical solids from their molecular structure.
44 Tervo AJ. Molecular Field-Based Activity Predictions and Virtual Screening in Computer-Aided Drug Design.
45 Tervo AJ et al. BRUTUS: Optimization of a grid-based similarity function for rigid-body molecular superposition. 1. alignment and virtual screening applications.
46 van Veen B et al. The effect of powder blend and tablet structure on drug release mechanisms of hydrophobic starch acetate matrix tablets.
47 Venäläinen JI et al. Synthesis and characterization of the novel fluorescent prolyl oligopeptidase inhibitor 4-fluoresceinthiocarbamoyl-6-aminocaproyl-L-prolyl-2(S)-(hydroxyacetyl)pyrrolidine.
48 Vepsäläinen JJ et al. Isolation and characterization of yuremamine, a new phytoindole.

Farmaseuttisen kemian laitos Department of Pharmaceutical Chemistry
Julkaisutietokanta 15.4.2008 Publications Data Base 15.4.2008